Target Validation Information | |||||
---|---|---|---|---|---|
TTD ID | T55815 | ||||
Target Name | Neuronal acetylcholine receptor alpha-2 (CHRNA2) | ||||
Type of Target |
Successful |
||||
Drug Potency against Target | Carbachol | Drug Info | Ki = 728 nM | [6] | |
Tubocurarine | Drug Info | Ki = 7770 nM | [6] | ||
(S)-3-(azetidin-2-ylmethoxy)-2-fluoropyridine | Drug Info | Ki = 180 nM | [5] | ||
1,1-Dimethyl-4-phenyl-piperazin-1-ium iodide | Drug Info | Ki = 1300 nM | [1] | ||
1-(piperidin-3-ylmethyl)pyridin-2(1H)-one | Drug Info | Ki = 4630 nM | [4] | ||
1-(piperidin-4-ylmethyl)pyridin-2(1H)-one | Drug Info | Ki = 3600 nM | [4] | ||
2-Pyridin-3-yl-7-aza-bicyclo[2.2.1]heptane | Drug Info | Ki = 3.3 nM | [2] | ||
3-((S)-Azetidin-2-yloxy)-5-iodo-pyridine | Drug Info | Ki = 47 nM | [1] | ||
5-(1-Methyl-pyrrolidin-2-yl)-2-phenethyl-pyridine | Drug Info | Ki = 1200 nM | [3] | ||
CHOLINE | Drug Info | Ki = 18000 nM | [1] | ||
CYTISINE | Drug Info | Ki = 5.41 nM | [4] | ||
References | |||||
REF 1 | Pharmacology of the agonist binding sites of rat neuronal nicotinic receptor subtypes expressed in HEK 293 cells. Bioorg Med Chem Lett. 2004 Apr 19;14(8):1845-8. | ||||
REF 2 | Epibatidine structure-activity relationships. Bioorg Med Chem Lett. 2004 Apr 19;14(8):1889-96. | ||||
REF 3 | 6-(2-Phenylethyl)nicotine: a novel nicotinic cholinergic receptor ligand. Bioorg Med Chem Lett. 2005 Jul 1;15(13):3237-40. | ||||
REF 4 | Synthesis and pharmacological evaluation of novel 9- and 10-substituted cytisine derivatives. Nicotinic ligands of enhanced subtype selectivity. J Med Chem. 2006 May 4;49(9):2673-6. | ||||
REF 5 | Synthesis and biological evaluation of novel carbon-11 labeled pyridyl ethers: candidate ligands for in vivo imaging of alpha4beta2 nicotinic acety... Bioorg Med Chem. 2009 Jul 1;17(13):4367-77. | ||||
REF 6 | Receptor binding thermodynamics at the neuronal nicotinic receptor. Curr Top Med Chem. 2004;4(3):361-8. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.